NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability

Summary

NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability (MONDO:0800475) is a disease. A subtype of intellectual disability — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability
Mondo ID	MONDO:0800475
GARD	0027073
Is cancer (heuristic)	no

Also known as: NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability

Disease family

This is a subtype of intellectual disability. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › neurodevelopmental disorder › intellectual disability › NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability

Related subtypes (9): syndromic intellectual disability, non-syndromic intellectual disability, intellectual developmental disorder and retinitis pigmentosa; IDDRP, PPP2R1A-related intellectual disability, intellectual disability, autosomal dominant, X-linked intellectual disability, intellectual disability, autosomal recessive, SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth, intellectual developmental disorder with polymicrogyria and seizures

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.